Making a case for acute ischemic stroke

Journal of Pharmacy Practice

Volumn 23, Issue 5, 2010, Pages 387-397

  Baldwin, Kathleen A ^a   McCoy, Stacey L ^a  

^a BAPTIST MEDICAL CENTER   (United States)

Author keywords

acute ischemic stroke; neuroendovascular; reperfusion; rt PA; thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CITICOLINE; CLOPIDOGREL; DESMOTEPLASE; DIPYRIDAMOLE; ENOXAPARIN; HEPARIN; MINOCYCLINE; SIMVASTATIN;

ADL DISABILITY; APHASIA; BODY TEMPERATURE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CRYSTALLOID; DEPRESSION; EMERGENCY HEALTH SERVICE; FEVER; HEMIPARESIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSTITUTIONALIZATION; MONOTHERAPY; NONHUMAN; OXYGENATION; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT TRANSPORT; REPERFUSION; REST; REVIEW; VENOUS THROMBOEMBOLISM; WALKING DIFFICULTY;

EID: 78650019512     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190010372325     Document Type: Review

References (63)

1. Adams HP, Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multi-center clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke. 1993 ; 24 (1). 35-41.
2. Briggs DE, Felberg RA, Malkoff MD, et al. Should mild or moderate stroke patients be admitted to an intensive care unit ? Stroke. 2001 ; 32 (4). 871-876.
3. Stroke Scales and Clinical Assessment Tools: Modified Rankin scale. http://www.strokecenter.org/trials/scales/rankin.html. Accessed November 13, 2009.
4. American Heart Association Stroke Warning Signs. http://www. americanheart.org/presenter.jhtml?identifier=4742. Accessed October 24, 2009.
5. Stroke symptoms. http://www.stroke.org/site/PageServer?pagename=symp. Accessed May 31, 2010.
6. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 ; 119 (3). 480-486.
7. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 ; 119 (3). e21 - e181.
8. About stroke: stroke statistics. http://www.strokecenter.org/patients/ stats.htm. Accessed October 24, 2009.
9. Stroke in perspective: risk factors. http://www.strokecenter.org/ patients/stats.htm. Accessed May 31, 2010.
10. Goldstein LB, Adams R., Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke. 2006 ; 37 (6). 1583-1633.
11. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 ; 285 (19). 2486-2497.
12. Putaala J., Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009 ; 40 (4). 1195-1203.
13. Wolf PA, Abbott RD, Kannel WB Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991 ; 22 (8). 983-988.
14. Boden-Albala B., Sacco RL, Lee HS, et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke. 2008 ; 39 (1). 30-35.
15. Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke. 2001 ; 32 (6). 1271-1278.
16. Bassetti CL, Milanova M., Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke. 2006 ; 37 (4). 967-972.
17. Top things to know: sleep apnea and cardiovascular disease. http://www.americanheart.org/downloadable/heart/1216932700407topTenSleepApnea. pdf. Accessed November 19, 2010.
18. Adams HP Jr, del Zoppo G., Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 ; 38 (5). 1655-1711.
19. Kurth T. Associations between migraine and cardiovascular disease. Expert Rev Neurother. 2007 ; 7 (9). 1097-1104.
20. Wassertheil-Smoller S., Hendrix SL, Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA. 2003 ; 289 (20). 2673-2684.
21. Bandera E., Botteri M., Minelli C., et al. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke. 2006 ; 37 (5). 1334-1339.
22. Rose JC, Mayer SA Optimizing blood pressure in neurological emergencies. Neurocrit Care. 2004 ; 1 (3). 287-299.
23. Stroke Scale and Clinical Assessment tools: Cincinnati Stroke Scale http://www.strokecenter.org/trials/scales/cincinnati.html. Accessed November 13, 2009.
24. Joint Commission Fact Sheets: Facts about Primary Stroke Center Certification. http://www.jointcommission.org/AboutUs/Fact-Sheets/psc- certification.htm. Accessed November 13, 2009.
25. National Institute of Stroke: Stroke Centers and Rehabilitation Facilities. http://www.stroke.org/site/PageServer?pagename=RESOUR. Accessed November 13, 2009.
26. Switzer JA, Hess DC Development of regional programs to speed treatment of stroke. Curr Neurol Neurosci Rep. 2008 ; 8 (1). 35-42.
27. Saposnik G., Kapral MK, Coutts SB, et al. Do all age groups benefit from organized inpatient stroke care? Stroke. 2009 ; 40 (10). 3321-3327.
28. Foerch C., Montaner J., Furie KL, et al. Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology. 2009 ; 73 (5). 393-399.
29. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995 ; 333 (24). 1581-1587.
30. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 ; 359 (13). 1317-1329.
31. Saver JL, Gornbein J., Grotta J., et al. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial Stroke. 2009 ; 40 (7). 2433-2437.
32. Del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009 ; 40 (8). 2945-2948.
33. Hacke W., Donnan G., Fieschi C., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 ; 363 (9411). 768-774.
34. Smith WS, Sung G., Saver J., et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008 ; 39 (4). 1205-1212.
35. Bose A., Henkes H., Alfke K., et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol. 2008 ; 29 (7). 1409-1413.
36. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009 ; 40 (8). 2761-2768.
37. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008 ; 39 (4) 1205-1212.
38. Investigators. Tiit. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007 ; 38 (7). 2127-2135.
39. Pancioli AM, Broderick J., Brott T., et al. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke. 2008 ; 39 (12). 3268-3276.
40. IMS-III: The Interventional Management of Stroke (IMS) III Trial. http://www.strokecenter.org/trials/trialDetail.aspx?tid=747&search
41. Albers GW, Amarenco P., Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 ; 133 (6 suppl). 630S - 669S.
42. Meyer DM, Albright KC, Allison TA, et al. LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 2008 ; 17 (1). 26-29.
43. Kennedy J., Hill MD, Ryckborst KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007 ; 6 (11). 961-969.
44. Dengler R., Diener HC, Schwartz A., et al. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010 ; 9 (2). 159-166.
45. Stead LG, Gilmore RM, Decker WW, et al. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology. 2005 ; 65 (8). 1179-1183.
46. Stead LG, Gilmore RM, Vedula KC, et al. Impact of acute blood pressure variability on ischemic stroke outcome. Neurology. 2006 ; 66 (12). 1878-1881.
47. Broderick J., Connolly S., Feldmann E., et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007 ; 38 (6). 2001-2023.
48. Sherman DG, Albers GW, Bladin C., et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet. 2007 ; 369 (9570). 1347-1355.
49. Capes SE, Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001 ; 32 (10). 2426-2432.
50. Quinn TJ, Lees KR Hyperglycaemia in acute stroke-to treat or not to treat. Cerebrovasc Dis. 2009 ; 27 (suppl 1). 148-155.
51. Johnston KC, Hall CE, Kissela BM, et al. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke. 2009 ; 40 (12). 3804-3809.
52. Bruno A., Kent TA, Coull BM, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke. 2008 ; 39 (2). 384-389.
53. Gray CS, Hildreth AJ, Alberti GK, et al. Poststroke hyperglycemia: natural history and immediate management. Stroke. 2004 ; 35 (1). 122-126.
54. NeuSTART II Neuroprotection with Statin Therapy for Acute Recovery Trial (Neu START): a phase 2 safety and pilot efficacy study of lovastatin for the treatment of acute ischemic stroke. http://www.strokecenter.org/trials/ TrialDetail.aspx?tid=971. Accessed November 13, 2009.
55. Amarenco P., Bogousslavsky J., Callahan, A. 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 ; 355 (6). 549-559.
56. Blanco M., Nombela F., Castellanos M., et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology. 2007 ; 69 (9). 904-910.
57. Sacco RL, Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 ; 37 (2). 577-617. (Pubitemid 43732031)
58. Clark WM Efficacy of citicoline as an acute stroke treatment. Expert Opin Pharmacother. 2009 ; 10 (5). 839-846.
59. Paciaroni M., Medeiros E., Bogousslavsky J. Desmoteplase. Expert Opin Biol Ther. 2009 ; 9 (6). 773-778.
60. Hacke W., Furlan AJ, Al- Rawi Y., et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2009 ; 8 (2). 141-150.
61. Lampl Y., Boaz M., Gilad R., et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology. 2007 ; 69 (14). 1404-1410.
62. MINOS: Minocycline to Improve Neurologic Outcome Study. http://www.strokecenter.org/trials/TrialDetail.aspx?tid=856. Accessed May 31, 2010.
63. Tsivgoulis G., Culp WC, Alexandrov AV Ultrasound enhanced thrombolysis in acute arterial ischemia. Ultrasonics. 2008 ; 48 (4). 303-311.